Inotiv provides general toxicology studies under internationally recognized regulatory guidelines for the safety evaluation of your small molecule, biotherapeutic drug candidate or medical device. Our experienced and proven scientific teams regularly contribute to successful Investigational New Drug application (IND), New Drug Application (NDA), and Biologic License Application (BLA) submissions. You will receive timely and reliable reports that meet regulatory requirements and guidelines, including eCTD compliant reports and SEND compliant datasets. Our diverse capabilities enable us to offer flexible, targeted solutions to meet your needs at various phases of your program. We can provide a full safety assessment solution including study designs, study conduct, sample analysis, and data interpretation—or you can take advantage of our standalone services.
As part of a Inotiv’s general toxicology program, we use rodent and non-rodent models offering:
Inotiv’s computational toxicology group offers you a wide range of expertise across informatics areas, allowing us to draw on data from your assays, in-house resources, and relevant literature to deliver the insights you need.
Copyright © 2023 Inotiv. All Rights Reserved.